TRAQinform IQ Commercial Deployment
Monitoring treatment response in metastatic cancer (e.g., lung, lymphoma, prostate)
CommercialActive
Key Facts
Indication
Monitoring treatment response in metastatic cancer (e.g., lung, lymphoma, prostate)
Phase
Commercial
Status
Active
Company
About AIQ Solutions
AIQ Solutions, founded in 2018 and based in Cambridge, Massachusetts, is a private diagnostics company operating at the intersection of AI and oncology. The company has developed and received FDA 510(k) clearance for TRAQinform IQ, a cloud-based software platform that analyzes serial PET/CT scans to measure intra-patient tumor response heterogeneity, providing prognostic insights superior to standard methods like RECIST. By enabling more precise therapy adjustments in late-stage cancer care, AIQ targets a significant unmet need in the oncology workflow, supported by recent clinical data and the establishment of a Category III CPT code for its service.
View full company profile